<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03320005</url>
  </required_header>
  <id_info>
    <org_study_id>Resist protocol</org_study_id>
    <nct_id>NCT03320005</nct_id>
  </id_info>
  <brief_title>EFFECTS OF RESISTANCE TRAINING IN ELDERLY</brief_title>
  <official_title>EFFECTS OF RESISTANCE TRAINING ON THE PHYSICAL AND FUNCTIONAL RESPIRATORY PERFORMANCE OF ELDERLY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daysi Tobelem</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nove de Julho</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This comes from a non-randomized clinical trial, which aims to check on elderly women the&#xD;
      effects of a program of resistance training (TR) in physical performance, in respiratory&#xD;
      functional capacity, on health and quality of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Will be measured the strength of the respiratory muscles (Mip and Mep), peak expiratory flow&#xD;
      (Peak-Flow), thoracic movements and abdominal movements, distance traveled in Incremental&#xD;
      Shuttle Walk Test, grip strength manual, pulmonary leukocytes, biochemical parameters and&#xD;
      indicators of quality of life and physical activity through the WHOQOL-old and IPAQ-short.&#xD;
      The data will be tested against the distribution of the Gauss curve, by the shapiro-wilk test&#xD;
      and, if they have a normal distribution (parametric) are expressed as mean and standard&#xD;
      deviation, if not submit normal (non parametric) distribution will be expressed as median or&#xD;
      range interquartílico. The first chance to compare the evolution of the group studied, will&#xD;
      be applied to two-way ANOVA. If the distribution is abnormal, it will apply Mann-Whitney&#xD;
      test. The multiple regression test will be used to compare the Mip and Mep with variables&#xD;
      with the Peak-Flow, Thoracoabdominal mobility, distance traveled, immune competence, physical&#xD;
      fitness and quality of life in the groups studied.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Physical performance</measure>
    <time_frame>Change from Baseline at 24 weeks</time_frame>
    <description>distance traveled on ISWT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>Change from Baseline at 24 weeks</time_frame>
    <description>quality of life (WHOQOL-old)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>respiratory muscle strength</measure>
    <time_frame>Change from Baseline at 24 weeks</time_frame>
    <description>respiratory pressures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hand grip</measure>
    <time_frame>Change from Baseline at 24 weeks</time_frame>
    <description>Hand grip test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Aging Disorder</condition>
  <arm_group>
    <arm_group_label>ResistanceTraining Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The RT program has the following features: 05 classes performing two weekly sessions; day shift; sessions with maximum duration of 1 (one) hour; 02 series; 08 to 12 repetitions; interval between sets of 01 to 02 minutes; exercises: bench press, seated leg press 45°, pull forward, Earth, rowing standing calf standing, power lifting, abdominal and development.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non training group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>sedentary elderly</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistance training group</intervention_name>
    <description>Resistive exercises for legs and arms</description>
    <arm_group_label>ResistanceTraining Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  60 year old or more&#xD;
&#xD;
          -  Do not have cardiac or respiratory diseases&#xD;
&#xD;
          -  neurological, Musculoskeletal and other diseases preventing the practice of exercises&#xD;
&#xD;
          -  not being a smoker; agree to participate in the study and signed an informed consent&#xD;
             (IC); in the last six months preceding the evaluation did not have participated in&#xD;
             physical activity program with the aim of improving physical performance.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Difficult to complete the tasks&#xD;
&#xD;
          -  Acute diseases&#xD;
&#xD;
          -  Refuse to continue the program&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dirceu Costa, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Nove de Julho University</affiliation>
  </overall_official>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>August 7, 2017</study_first_submitted>
  <study_first_submitted_qc>October 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2017</study_first_posted>
  <last_update_submitted>October 19, 2017</last_update_submitted>
  <last_update_submitted_qc>October 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Nove de Julho</investigator_affiliation>
    <investigator_full_name>Daysi Tobelem</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>respiratory performance</keyword>
  <keyword>quality of life</keyword>
  <keyword>physical performance</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

